Price T Rowe Associates Inc Vir Biotechnology, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 67,826 shares of VIR stock, worth $504,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,826
Previous 57,843 17.26%
Holding current value
$504,625
Previous $515,000 1.17%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.26 - $10.7 $72,476 - $106,818
9,983 Added 17.26%
67,826 $509,000
Q2 2024

Aug 14, 2024
BUY
$7.63 - $12.66 $34,060 - $56,514
4,464 Added 8.36%
57,843 $515,000
Q1 2024

May 15, 2024
SELL
$8.6 - $11.9 $285,735 - $395,377
-33,225 Reduced 38.36%
53,379 $541,000
Q4 2023

Feb 14, 2024
SELL
$7.76 - $10.29 $1.16 Million - $1.54 Million
-149,323 Reduced 63.29%
86,604 $872,000
Q3 2023

Nov 14, 2023
SELL
$9.14 - $24.62 $5.17 Million - $13.9 Million
-566,107 Reduced 70.58%
235,927 $2.21 Million
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $9.63 Million - $11.3 Million
415,089 Added 107.27%
802,034 $19.7 Million
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $28,871 - $40,012
1,297 Added 0.34%
386,945 $9.01 Million
Q4 2022

Feb 14, 2023
BUY
$19.96 - $28.22 $778 - $1,100
39 Added 0.01%
385,648 $9.76 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $3.82 Million - $6.5 Million
209,070 Added 118.43%
385,609 $7.44 Million
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $5.22 Million - $7.31 Million
-273,824 Reduced 60.8%
176,539 $4.5 Million
Q1 2022

May 16, 2022
SELL
$21.19 - $40.01 $3.12 Million - $5.88 Million
-147,070 Reduced 24.62%
450,363 $11.6 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $17.4 Million - $30.3 Million
560,914 Added 1535.95%
597,433 $25 Million
Q3 2021

Nov 15, 2021
SELL
$34.9 - $54.54 $1.37 Million - $2.15 Million
-39,334 Reduced 51.86%
36,519 $1.59 Million
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $537,617 - $707,574
13,874 Added 22.39%
75,853 $3.59 Million
Q1 2021

May 17, 2021
SELL
$26.34 - $83.07 $90,530 - $285,511
-3,437 Reduced 5.25%
61,979 $3.18 Million
Q4 2020

Feb 16, 2021
BUY
$25.51 - $43.38 $1.67 Million - $2.84 Million
65,416 New
65,416 $1.75 Million

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $987M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email